Chemoinformaics analysis of Isobutyl phenylacetate
| Molecular Weight | 192.258 | nRot | 4 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 8 |
| Exact Molecular Weight | 192.115 | nRing | 1 |
| Solubility: LogS | -2.573 | nHRing | 0 |
| Solubility: LogP | 3.107 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 32.3127 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.595 |
| Synth | 1.719 |
| Natural Product Likeliness | 0.392 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.009 |
| HIA | 0.003 |
| CACO-2 | -4.361 |
| MDCK | 0.0000278 |
| BBB | 0.968 |
| PPB | 0.808618 |
| VDSS | 1.148 |
| FU | 0.154338 |
| CYP1A2-inh | 0.728 |
| CYP1A2-sub | 0.562 |
| CYP2c19-inh | 0.219 |
| CYP2c19-sub | 0.146 |
| CYP2c9-inh | 0.214 |
| CYP2c9-sub | 0.454 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.283 |
| CYP3a4-inh | 0.076 |
| CYP3a4-sub | 0.126 |
| CL | 7.993 |
| T12 | 0.51 |
| hERG | 0.056 |
| Ames | 0.014 |
| ROA | 0.032 |
| SkinSen | 0.895 |
| Carcinogencity | 0.104 |
| EI | 0.99 |
| Respiratory | 0.34 |
| NR-Aromatase | 0.02 |
| Antiviral | No |
| Prediction | 0.678094 |